NASDAQ:PBLA

Panbela Therapeutics Stock Signals

etoro logo Buy PBLA
*Your capital is at risk
$0.0111
+0 (+0%)
At Close: Jul 13, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Panbela Therapeutics Inc.

General

Signal Type Signal Value Data
Score 0.000 95 days ( -47.02 %
Last Price $0.0111 0 %
Performance History
7 Days
$0.0111 $0.0111
0%
30 Days
$0.0111 $0.0111
0%
12 Mos
$0.210 $0.0111
-94.72%

8/18

Active Buy Signals

Specific Signals

Short Term
Net score: 64.86
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0111 - $0.0111
Trend - 3 mos 11.62 % High Width: 2,966.28 %
Pred. range - 3 mos $0.0005 - $0.0161 Low -95.26 % - 45.38 %
Volume Direction Sell High Volume: 27 · Direction: 0
Pivot Short Sell Very Low Jul 10, 2026 - 2 days
RSI Short Pivot Signal Buy Very Low Jul 02, 2026 - 7 days
Short MA 3 mos Buy Low Jun 26, 2026 - 11 days
Long MA 3 mos Buy Medium Jun 25, 2026 - 12 days
Short/Long MA 3 mos Buy Medium Jul 06, 2026 - 6 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 42.52
Signal Type Signal Value Importance Data
Trend - 12 mos -78.26 % Very High Width: 140.10 %
Pred. range - 12 mos N/A - $0.0084 High -100.00 % - -24.27 %
Short MA 12 mos Buy Very High Jul 02, 2026 - 7 days
Long MA 12 mos Buy Very High Jul 02, 2026 - 7 days
Short/Long MA 12 mos Buy Very High Jun 25, 2026 - 12 days
Pivot Long Sell Low Jul 10, 2026 - 2 days
RSI Long Pivot Signal Sell Low Jul 06, 2026 - 6 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT PANBELA THERAPEUTICS INC.
Panbela Therapeutics
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE